Association between C-reactive protein and atrial fibrillation recurrence after catheter ablation: A meta-analysis

Clinical Cardiology

Volumn 36, Issue 9, 2013, Pages 548-554

  Jiang, Zhouqin ^a   Dai, Limeng ^a   Song, Zhiyuan ^a   Li, Huakang ^a   Shu, Maoqin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; ASIAN; CATHETER ABLATION; CAUCASIAN; DISEASE ASSOCIATION; ETHNICITY; HEART ATRIUM FIBRILLATION; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; SCORING SYSTEM; STATISTICAL PARAMETERS; SYSTEMATIC REVIEW;

ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; CATHETER ABLATION; HUMANS; POSTOPERATIVE PERIOD; PROGNOSIS; RECURRENCE;

EID: 84883863455     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22157     Document Type: Article

References (42)

1. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285: 2370-2375.
2. Tsang TS, Petty GW, Barnes ME, et al. The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades. J Am Coll Cardiol. 2003; 42: 93-100.
3. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010; 31: 2369-2429.
4. Jais P, Cauchemez B, Macle L,et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation. 2008; 118: 2498-2505.
5. Oral H, Pappone C, Chugh A, et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med. 2006; 354: 934-941.
6. Wann LS, Curtis AB, Ellenbogen KA, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2011; 57: 1330-1337.
7. Calkins H, Brugada J, Packer DL, et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2007; 4: 816-861.
8. Cheema A, Vasamreddy CR, Dalal D, et al. Long-term single procedure efficacy of catheter ablation of atrial fibrillation. J Interv Card Electrophysiol. 2006; 15: 145-155.
9. Pappone C, Rosanio S, Oreto G, et al. Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation. 2000; 102: 2619-2628.
10. Wokhlu A, Hodge DO, Monahan KH, et al. Long-term outcome of atrial fibrillation ablation: impact and predictors of very late recurrence. J Cardiovasc Electrophysiol. 2010; 21: 1071-1078.
11. Korantzopoulos P, Kolettis T, Siogas K, et al. Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. Med Sci Monit. 2003; 9: RA225-RA229.
12. Engelmann MD, Svendsen JH,. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J. 2005; 26: 2083-2092.
13. Boos CJ, Anderson RA, Lip GY,. Is atrial fibrillation an inflammatory disorder? Eur Heart J. 2006; 27: 136-149.
14. Liu T, Li G,. Is atrial fibrillation an inflammatory disease? Med Hypotheses. 2005; 64: 1237-1238.
15. Watanabe T, Takeishi Y, Hirono O, et al. C-reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation. Heart Vessels. 2005; 20: 45-49.
16. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283: 2008-2012.
17. Whitlock RP, Chan S, Devereaux PJ, et al. Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials. Eur Heart J. 2008; 29: 2592-2600.
18. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7: 177-188.
19. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315: 629-634.
20. Letsas KP, Weber R, Burkle G, et al. Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation. Europace. 2009; 11: 158-163.
21. Henningsen KM, Nilsson B, Bruunsgaard H, et al. Prognostic impact of hs-CRP and IL-6 in patients undergoing radiofrequency catheter ablation for atrial fibrillation. Scand Cardiovasc J. 2009; 43: 285-291.
22. Liu J, Fang PH, Dibs S, et al. High-sensitivity C-reactive protein as a predictor of atrial fibrillation recurrence after primary circumferential pulmonary vein isolation. Pacing Clin Electrophysiol. 2011; 34: 398-406.
23. Lin YJ, Tsao HM, Chang SL, et al. Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fibrillation. Am J Cardiol. 2010; 105: 495-501.
24. Okumura Y, Watanabe I, Nakai T, et al. Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence. J Cardiovasc Electrophysiol. 2011; 22: 987-993.
25. Fan J, Cao H, Su L, et al. NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation. J Interv Card Electrophysiol. 2012; 33: 93-100.
26. Kornej J, Reinhardt C, Kosiuk J, et al. Response of high-sensitive C-reactive protein to catheter ablation of atrial fibrillation and its relation with rhythm outcome. PLoS One. 2012; 7: e44165.
27. Patel P, Dokainish H, Tsai P, et al. Update on the association of inflammation and atrial fibrillation. J Cardiovasc Electrophysiol. 2010; 21: 1064-1070.
28. Frustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997; 96: 1180-1184.
29. Nakamura Y, Nakamura K, Fukushima-Kusano K, et al. Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis. Thromb Res. 2003; 111: 137-142.
30. Chang SL, Tsao HM, Lin YJ, et al. Characteristics and significance of very early recurrence of atrial fibrillation after catheter ablation. J Cardiovasc Electrophysiol. 2011; 22: 1193-1198.
31. Kaptoge S, Di Angelantonio E, Lowe G, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010; 375: 132-140.
32. Ridker PM, Rifai N, Stampfer MJ, et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000; 101: 1767-1772.
33. Narducci ML, Pelargonio G, Dello Russo A, et al. Role of tissue C-reactive protein in atrial cardiomyocytes of patients undergoing catheter ablation of atrial fibrillation: pathogenetic implications. Europace. 2011; 13: 1133-1140.
34. Dernellis J, Panaretou M,. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J. 2004; 25: 1100-1107.
35. Lellouche N, Jais P, Nault I, et al. Early recurrences after atrial fibrillation ablation: prognostic value and effect of early reablation. J Cardiovasc Electrophysiol. 2008; 19: 599-605.
36. Tao H, Liu X, Dong J, et al. Predictors of very late recurrence of atrial fibrillation after circumferential pulmonary vein ablation. Clin Cardiol. 2008; 31: 463-468.
37. Jais P, Haissaguerre M, Shah DC, et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation. 1997; 95: 572-576.
38. Neumann T, Vogt J, Schumacher B, et al. Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. J Am Coll Cardiol. 2008; 52: 273-278.
39. Scharf C, Boersma L, Davies W, et al. Ablation of persistent atrial fibrillation using multielectrode catheters and duty-cycled radiofrequency energy. J Am Coll Cardiol. 2009; 54: 1450-1456.
40. Lee G, Sanders P, Kalman JM,. Catheter ablation of atrial arrhythmias: state of the art. Lancet. 2012; 380: 1509-1519.
41. Lubitz SA, Fischer A, Fuster V,. Catheter ablation for atrial fibrillation. BMJ. 2008; 336: 819-826.
42. Husser D, Adams V, Piorkowski C, et al. Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2010; 55: 747-753.